Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
Conditions: Non Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Urothelial Carcinoma; Malignant Mesothelioma Interventions: Drug: Cabozantinib; Drug: Pemetrexed Sponsor: Augusta University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Asbestosis | Cancer | Cancer & Oncology | Carcinoma | Lung Cancer | Mesothelioma | Non-Small Cell Lung Cancer | Research